中西医结合治疗原发性中晚期肝癌疗效对照观察

发布时间：2018-08-12 14:14

【摘要】：目的:探讨肝动脉栓塞化疗(TACE)联合氩氦刀及中药序贯治疗不能手术切除的原发性中晚期肝癌的价值和疗效。方法:75例不能手术切除的巨块型肝癌患者,随机分为3组:A组:单纯TACE治疗组23例;B组:TACE+氩氦刀治疗组26例;C组:TACE+氩氦刀+中药治疗组26例。结果:A组术后肿瘤完全坏死率及初次复发率、术后12个月、18个月生存率分别为26.08%、47.82%、56.52%、43.48%;B组分别为61.54%、11.54%、84.61%、73.08%;C组分别为69.23%、7.69%、88.46%、80.77%。结论:TACE术联合氩氦刀及中药序贯治疗原发性中晚期肝癌是一种疗效确切、安全可靠的综合治疗方法,并可能成为非外科手术治疗肝癌的发展方向。
[Abstract]:Objective: to evaluate the value and efficacy of transcatheter arterial chemoembolization (TACE) combined with argon-helium knife and traditional Chinese medicine in the treatment of unresectable primary and advanced hepatocellular carcinoma. Methods Seventy-five unresectable giant hepatocellular carcinoma patients were randomly divided into three groups: TACE group (n = 23), group B (n = 26), group C (n = 26), group B (n = 26). Results the total necrosis rate and the first recurrence rate of tumor in group A were 26.08 and 47.82, respectively. The survival rates of group B were 61.54 and 11.5411.5411.5411.5411.5411.544.61and 73.08C were 69.237.697.6988. 466.46and 80.7775, respectively61.544.54.61and the survival rates of group C were 69.237.697.698.466.46 and 88.466.77, respectively61.544.544.61and 69.237.698.The survival rate of group B was 69.237.696.46. Conclusion the sequential treatment of primary and advanced hepatocellular carcinoma with the combination of worst-TACE and argon-helium knife and traditional Chinese medicine is an effective, safe and reliable comprehensive treatment method, and may be the development direction of non-surgical treatment of liver cancer.
【作者单位】：广西中医学院附属瑞康医院广西中医学院附属瑞康医院广西中医学院附属瑞康医院广西中医学院附属瑞康医院广西中医学院附属瑞康医院广西中医学院附属瑞康医院广西中医学院附属瑞康医院
【分类号】：R735.7

【相似文献】